[Skip to Content]
[Skip to Content Landing]
Editorial
July 2017

Cancer Screening, Overdiagnosis, and Regulatory Capture

Author Affiliations
  • 1Dartmouth Institute of Health Policy and Clinical Practice, Geisel School of Medicine, Hanover, New Hampshire
JAMA Intern Med. 2017;177(7):915-916. doi:10.1001/jamainternmed.2017.1198

The US Preventive Services Task Force (USPSTF) has given thyroid cancer screening a D grade, recommending against screening.1 They conclude with moderate certainty that screening for thyroid cancer in asymptomatic persons results in harms that outweigh the benefits. Given the historical context—both in pathology and medical care epidemiology—it should have been an easy decision.

×